╔══════════════════════════════════════════════════════════════╗
║          MEDICAL LABORATORY REPORT                           ║
║          General Hospital - Clinical Lab                     ║
╚══════════════════════════════════════════════════════════════╝

Patient Name: Ashmitha B
Patient ID: ASH-2026-001
Date: February 6, 2026
Time: 09:30 AM

VITAL SIGNS DURING COLLECTION:
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Temperature: 37.2°C
Blood Pressure: 120/80 mmHg
Heart Rate: 78 bpm
Oxygen Saturation (SpO2): 98%
Pain Level: 2/10

COMPLETE BLOOD COUNT (CBC):
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
White Blood Cells (WBC): 7.5 x10³/µL (Normal: 4.5-11.0)
Red Blood Cells (RBC): 4.8 x10⁶/µL (Normal: 4.5-5.9)
Hemoglobin: 14.2 g/dL (Normal: 13.5-17.5)
Hematocrit: 42% (Normal: 38.8-50.0)
Platelets: 250 x10³/µL (Normal: 150-400)

METABOLIC PANEL:
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Glucose: 95 mg/dL (Normal: 70-100)
Creatinine: 1.0 mg/dL (Normal: 0.7-1.3)
Blood Urea Nitrogen (BUN): 15 mg/dL (Normal: 7-20)

INFLAMMATORY MARKERS:
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
C-Reactive Protein (CRP): 2.1 mg/L (Normal: <3.0)
Erythrocyte Sedimentation Rate: 12 mm/hr (Normal: 0-20)

CLINICAL INTERPRETATION:
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
✓ All parameters within normal post-surgical range
✓ No signs of infection or inflammation
✓ WBC count stable, indicating good immune response
✓ Hemoglobin levels normal - adequate oxygen carrying capacity
✓ Inflammatory markers (CRP) within acceptable limits
✓ Metabolic function stable

RECOMMENDATIONS:
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
• Continue current medication regimen
• Maintain adequate hydration
• Follow-up in 2 weeks
• Monitor for any fever or increased pain

Reviewed by: Dr. Sarah Mitchell, MD
Lab Technician: John Davis, MLT
Report Status: FINAL

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
This is a confidential medical document. Unauthorized distribution prohibited.
